昆明医科大学学报2026，Vol.47Issue(2)：1-13,13.DOI:10.12259/j.issn.2095-610X.S20260201
阿尔茨海默病中神经炎症生物标志物及相关药物治疗研究进展
Neuroinflammatory Biomarkers and Related Pharmacological Treatment in Alzheimer's Disease
摘要
Abstract
Alzheimer's disease(AD)is one of the most common chronic neurodegenerative disorders,characterized by a series of pathological processes.Neuroinflammation,marked by activation of the glial cell system,constitutes a key component of AD pathogenesis.Timely prevention of neuroinflammation or monitoring of inflammatory responses may serve as a prospective therapeutic approach for AD.This article reviews the potential application value of neuroinflammation biomarkers in early diagnosis of AD and their clinical significance in disease progression,and summarizes the current therapeutic research progress on AD-related neuroinflammation drugs,with the aim of providing reference for subsequent research and clinical practice in this field.关键词
阿尔茨海默病/神经炎症/生物标志物/药物治疗Key words
Alzheimer's disease/Neuroinflammation/Biomarkers/Drug therapy分类
医药卫生引用本文复制引用
马自蓉,张少川,曹雪,王宇涛,李庆蓉..阿尔茨海默病中神经炎症生物标志物及相关药物治疗研究进展[J].昆明医科大学学报,2026,47(2):1-13,13.基金项目
国家自然科学基金(82501446) （82501446）
云南省临床医学中心科研项目(2024YNLCYXZX0271) （2024YNLCYXZX0271）
云南省科技厅-昆明医科大学应用基础研究联合专项基金(202401AY070001-313) （202401AY070001-313）
昆明市卫生科技人才培养"十百千"学科带头人[2022-SW(带头)-31] （带头）
